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Abstract
Reaching hard-to-reach and high-risk injecting drug users (IDUs) is one of the most important
challenges for contemporary needle syringe programs (NSPs). The aim of this review is to examine,
based upon the available international experience, the effectiveness of syringe vending machines
and mobile van/bus based NSPs in making services more accessible to these hard-to-reach and high-
risk groups of IDUs. A literature search revealed 40 papers/reports, of which 18 were on
dispensing machines (including vending and exchange machines) and 22 on mobile vans. The findings
demonstrate that syringe dispensing machines and mobile vans are promising modalities of NSPs,
which can make services more accessible to the target group and in particular to the harder-to-
reach and higher-risk groups of IDUs. Their anonymous and confidential approaches make services
attractive, accessible and acceptable to these groups. These two outlets were found to be
complementary to each other and to other modes of NSPs. Services through dispensing machines
and mobile vans in strategically important sites are crucial elements in continuing efforts in reducing
the spread of HIV and other blood borne viruses among IDUs.
Introduction
HIV transmission associated with sharing of contami-
nated injecting equipment is now a global problem, with
more than 110 countries having reported HIV transmis-
sion in this context [1]. World Health Organisation
(WHO) estimates approximately 10% of all new HIV
infections globally can be attributed to the sharing of con-
taminated injecting equipment [2]. In many parts of the
world injecting drug users (IDUs) comprise a far higher
proportion of new HIV infections, for example 72% of
new HIV infections in Ukraine [3]. An injecting drug user
infected with HIV can cause a cascade of new infections in
other individuals, not only through sharing of contami-
nated injecting equipment but also through sexual and
perinatal transmission. Hepatitis C and B, two other
blood-borne viruses, are far more easily transmitted by
blood-blood contact than HIV [4,5] and carry the risk of
cirrhosis.
Having experienced the limited outcomes of efforts to sig-
nificantly eliminate supply and demand for illicit drugs by
law enforcement, and in the face of rising prevalence of
HIV and other blood-borne viruses, there has been a
growing urgency to implement more effective prevention
responses to prevent transmission of blood-borne viruses
among IDUs. Therefore, authorities have adopted a more
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realistic approach to drug policy, termed as 'Harm Reduc-
tion' or 'Harm minimisation' in which reduction of
adverse consequences of drug use is valued as high prior-
ity at least as important as reducing demand and supply.
The Needle Syringe Program (NSP) or Needle Exchange
Program (NEP) is a fundamental component of harm
reduction that supports access to sterile injecting equip-
ment for IDUs and discourages sharing of used injecting
equipment. Preventive measures through NSP will remain
the most effective tool available to reduce the spread of
HIV among and from IDUs until an effective and widely
deployed vaccine is available.
NSP disease prevention efforts are dependent in part on
their ability to attract and maintain contact with IDUs so
that injecting equipment, and also education and referrals
can be provided. However, IDUs often avoid service pro-
viders until a crisis emerges, because they perceive interac-
tions in service settings can be embarrassing, degrading,
unhelpful and can be offered at locations and times
incompatible with their lives [6]. To overcome these diffi-
culties, a variety of measures have been developed to
improve access to and utilization of sterile injecting
equipment, and to increase choice for users. These include
several methods for distribution, sale or exchange of
injecting equipment such as conventional NSPs (housed
in a fixed location where IDUs are attended by health
staff), pharmacy-based distribution or exchange, dispens-
ing machines (that either sell injecting equipment, pro-
vide it for free or in exchange for used equipment) and
outreach programmes – often using a mobile van or bus
and sometimes through home-visits. In addition, health
education and safer injecting advice has been provided.
Services through dispensing machines and mobile vans
have been reported to be responsive to a wider range of
IDUs and most importantly to hidden and harder-to-
reach IDUs in the community, who for several reasons do
not or cannot attend conventional NSPs [7,8]. The aim of
this review is to examine the available evidence for the
effectiveness of syringe dispensing machines and mobile
van or bus based NSPs in making services accessible to
hard-to-reach and high-risk groups of IDUs.
Methods
Journal publications, conference presentations and pro-
ceedings, evaluation reports, and other relevant organiza-
tional reports relating to supply of sterile injecting
equipment through dispensing machines and/or mobile
vans were identified by a comprehensive search of elec-
tronic databases such as Medline, Medscape, Current
Contents, HealthSTAR, CAB Abstracts, Aidsline, Sociolog-
ical Abstracts and CINAHL. In addition, experts involved
with development and evaluation of current programs or
policy were contacted for official reports, policy docu-
ments or unpublished materials. In total, 40 papers/
reports were found that primarily focused on dispensing
machines and/or mobile vans, of which 18 focused on
dispensing machines and 22 on mobile vans.
Results
Introduction of dispensing machines and mobile vans to 
NSP
Syringe dispensing machines were first introduced in
Copenhagen, Denmark in June 1987 [9] then a few
months later in Larvik, Norway. Subsequently they were
introduced in several European countries including Swit-
zerland, Germany, France, Italy, the Netherlands, Austria,
and also in Australia and New Zealand. These are auto-
matic commercial dispensing machines that exchange
new for used syringes, or provide sterile equipment for a
coin or free-of-cost. These machines are also known as
'syringe exchange machines', 'syringe vending machines',
'syringe automat' or 'FITPACK® vending machines' (in
Australia), 'electronic dispenser', 'distribox®' or sometimes
simply 'slot machines'. New Zealand introduced a mobile
dispensing machine which is wheeled to a front doorway
and locked there. This design enables exchange services to
continue after hours in a safer way [10].
The NSP-mobile van was first introduced one year earlier,
in 1986, in Amsterdam, the Netherlands. It was, in fact, a
methadone dispensing bus that also offered syringe and
needle exchange [11]. In the same year health workers in
London and Liverpool started to exchange needles and
syringes using mobile vans [12]. In some settings this
form of NSP is known as a 'roving van' or 'mobile bus' or
simply 'mobile outlet'. Mobile vans have received much
more acceptance than dispensing machines and have
been introduced more widely.
The rationale for dispensing machines and mobile vans in 
NSPs
Each of these approaches offers the potential to provide
injecting equipment to hard-to-reach and high-risk
groups of IDUs. For example, some IDUs are concerned to
remain anonymous and fear that they may be identified if
they try to access sterile injecting equipment from phar-
macies or conventional NSPs [13-15]. Many IDUs need
access to services in the evening, at night or in weekends.
These users strongly feel the need for a non-contact and
out of business hours service and consequently dispens-
ing machines were introduced to supply sterile needles
and syringes together with condoms, health information
pamphlets and other minor health supplies [16]. Dod-
ding & Gaughwin [17] reported that one of the main rea-
sons identified by Australian IDUs for sharing injecting
equipment was the relative unavailability of sterile inject-
ing equipment, particularly outside the operating times of
pharmacies and conventional NSPs. If attempts are made
to continue conventional NSPs at nights and weekends,Harm Reduction Journal 2007, 4:14 http://www.harmreductionjournal.com/content/4/1/14
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staffing may be difficult or expensive and also staff may
see the work as risky. Dispensing machines overcome
these staffing problems. The possibility that judgmental
attitudes of some pharmacy staff and NSP staff might dis-
courage some IDUs from obtaining sterile injecting equip-
ment [18,19] was another consideration.
Unlike dispensing machines, mobile vans do not provide
completely anonymous access to sterile injecting equip-
ment, but peer staffed mobile vans can render a congenial
environment that provides near anonymous access.
Mobile vans can cover a greater geographic area and can
more readily accommodate changes in local conditions. A
van of this sort generally follows a relatively consistent
route, and parks at a predictable location at a predictable
time, although it can change in response to immediate
neighbourhoods' conditions (e.g., increased police pres-
ence) or to incorporate additional populations of inject-
ing drug users. One van may visit multiple sites in a single
outing. It can provide the benefits of both a fixed and a
mobile site. In addition, it can also provide shelter and
some security for staff, some privacy for clients, and a con-
sistent service while covering a large geographic area. A
roving site also keeps staff members and clients relatively
inconspicuous to neighbours, local business people, and
police officers.
Reaching hidden and hard-to-reach IDUs
A subgroup of IDUs are largely marginalised, isolated and
socially excluded and highly mobile[54]. They are often
not in contact with any services, as they are either unaware
of them or do not wish to access them. Corr [54] charac-
terised these groups as drug users who are mostly home-
less, female, younger, chaotic and from an ethnic
minority. Prisoner IDUs form another important high-
risk group. Beginner-IDUs are also hard-to-reach and usu-
ally do not define themselves as drug addicts and do not
approach NSPs or drug treatment units. None of these
groups are mutually exclusive and when these characteris-
tics are multiplied in the same individual, the person is
likely to suffer increasing marginalisation [55]. They are
highly susceptible to potential adverse health outcomes,
particularly blood-borne virus infections as their risky
behaviours often go unrecognized. Of the studies/reports
reviewed, 37 presented data/results on the ability of dis-
pensing machines and/or mobile vans to reach hidden
and hard-to-reach IDUs (Table 1).
Dispensing machines
Few studies have attempted to evaluate whether dispens-
ing machines attract hidden, hard-to-reach or high-risk
IDUs. Perhaps the most comprehensive studies were per-
formed in Marseille, France where it was found that pri-
mary users of vending machines were significantly
younger and less likely to live in a house they personally
owned or rented; they were also less likely to have been in
opioid maintenance treatment [39]. The researchers con-
cluded that the machine outlet seemed to effectively
attract a relatively hidden [7] and high-risk segment of
IDUs who are less likely to be reached by other programs
[39]. In the same city Moatti et al. [45] reported that users
of vending machines were younger than those who
Table 1: Ability of NSP-mobile vans and dispensing machines to reach high-risk and/or hidden IDUs.
Syringe dispensing machines Mobile vans
Ref. Location Reached high-risk 
and/or hidden IDUs
Ref. Location Reached high-risk 
and/or hidden IDUs
[20] Vestfold, Norway Yes [21] Paris, France Yes
[22] Rotterdam, the Netherlands Yes [23] Paris, France Yes
[24] Milan, Italy Yes [25] Geneva, Switzerland NM
[26] Sydney, Australia Yes [27] Rome, Italy Yes
[28] Berlin, Germany Yes [29] Spain Yes
[30] Berlin, Germany Yes [31] Rockville, USA Yes
[32] New South Wales, Australia Yes [33] Vancouver, Canada Yes
[17] Perth and Adelaide, Australia Yes, it will* [34] Wisconsin, USA Yes
[35] Hindelbank, Switzerland Yes [36] Baltimore, USA Yes
[37] Realta, Switzerland Yes [38] Sicily, Italy Yes
[39] Marseille, France Yes [8] Baltimore, USA Yes
[40] Vechta, Germany Yes [41] St. Petersburg, Russia Yes
[42] Kalgoorlie, Australia Yes [43] Oslo, Norway Yes
[9] Bremen, Germany NM [44] Sofia, Bulgaria Yes
[45] Marseille, France Yes [46] Vancouver, Canada Yes
[47] Lichtenberg, Lehrter Strasse, Germany Yes [48] Madrid, Valencia and some other places of Spain Yes
[49] Hamburg-Vierlande, Germany NM [50] Vilnius, Lithuania Yes
[51] New Heaven, CT, USA Yes
[52] Canberra, Australia Yes [53] Melbourne, Australia Yes
* Perception of focus group IDUs and health staff. NM = Not mentionedHarm Reduction Journal 2007, 4:14 http://www.harmreductionjournal.com/content/4/1/14
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accessed pharmacy or NSP for needle-syringe and tended
to have a lower socioeconomic status. They were signifi-
cantly less likely than pharmacy users to have a regular
job, and more likely than NSP users to be without any
resources. Stark et al. [30], in their vending machine study
in Berlin, found that machines users were more likely to
report a shorter history of injection. The authors
explained that early in their injection career IDUs may
prefer to obtain injecting equipment anonymously from
vending machines. They may not yet consider themselves
drug dependent, and may not be willing to contact staffed
agencies. This explanation was supported by their find-
ings that only 33% of the IDUs reported current contacts
with counselling units. This rate was significantly lower in
those with a shorter history of injecting. Similarly Leicht
[28] reported that novice IDUs are the main users of
machines with most having no contact with other helping
agencies for IDUs'. Based upon the findings of a study in
Italy, Agnoletto et al [24] underscored the need for com-
plementary use of both exchange machines and mobile
vans to modify risk behaviours of drug users who are not
in contact with health services.
Evaluation of dispensing machines in Norway showed
that these were a successful method of providing sterile
equipment to a group until then difficult to reach [20].
Comparable results had also been observed from all the
studies in Australia. Dodding & Gaughwin [17] reported
that because of the small populations in rural towns, the
confidentiality of IDUs in those areas can be particularly
important and vending machines may be a valuable form
of NSP. Most participants (IDUs and health workers) in
this study believed that some IDUs in these areas do not
use their local NSPs or pharmacies because of concern for
anonymity.
Prisoner-IDUs are at very high risk of blood-borne infec-
tions. A range of interlinking factors compound this risk –
the large number of IDUs, scarcity of sterile injecting
equipment and correspondingly higher prevalence of nee-
dle-syringe sharing, rapid turnover of prison populations
and hence far more changes in injecting partners [56].
Syringe exchange machines were found to be very effective
in increasing access to sterile injecting equipment in pris-
ons in Switzerland and Germany. Their easier and round-
the-clock access, high-degree of anonymity; better accept-
ance by inmates and better control of syringe disposal
(one-for-one exchange) made these machines a useful
mode of syringe exchange. The availability of injecting
equipment through dispensing machines did not lead to
an increase in drug use or injection frequency and syringe
sharing reduced significantly [47]. Stöver & Jacob [40]
reported that anonymous access through exchange
machines in a Women's Prison made it more acceptable
to the inmates than manual distribution in a Men's
Prison. The authors concluded that the level of acceptance
among prisoners largely depended on whether anonymity
is maintained during needle exchange. However, unfortu-
nately with political changes, all but one syringe exchange
machine in prisons in Germany have been removed. Only
Lichtenberg-Berlin still offers syringes.
Mobile vans
Overall findings suggest that mobile van outlets of NSPs
are effective in reaching hidden and high-risk group of
IDUs. A large study (n = 1020) in Vancouver compared
risk taking behaviours of IDUs attending conventional,
and mobile van needle exchanges [46]. This demonstrated
increasing risk profiles from IDUs who attend pharmacy,
to those who attend conventional NSPs to mobile
exchange van clients. Van users were more likely to be
younger, Indigenous and female. These results are consist-
ent with another Vancouver study [33], which compared
van to conventional NSP users. Van users were found to
inject more frequently, inject more frequently on the
street, be younger, more likely to engage in sex work and
less likely to be enrolled in a drug treatment program.
Riley et al. [36] studied new clients of both a mobile van
and of a pharmacy-based NEP in the same neighbour-
hood in Baltimore. They found that the van attracted
twice as many high-frequency injectors. Similarly, "Blue
Bus" exchange in Lithuania reports successfully reaching a
particular local community, identified as one of the most
at risk groups, where injecting drug use is common. A sur-
vey conducted to evaluate the impact of the Blue Bus serv-
ice on injecting practices of its clients revealed that within
the previous 30 days 96% of IDUs reported they did not
utilize used syringes, 88% did not share used syringes and
needles with others, and 92% said they did not buy
syringes already filled with a narcotic [50].
According to official data from the Ministry of Health, less
than half the IDUs in Rome were in touch with drug
dependence treatment units during 1992. However, with
the aid of an outreach mobile van, 1023 (52.5%) new
IDUs (who were not attending other services) were pro-
vided with services from the van in a one year period dur-
ing 1992–93 [27]. Similarly, a mobile van outreach
program in Spain encountered 1,745 new clients in only
a 9 month period [29]. Comparable results have been
reported on an evaluation of a pilot program using a
camper van in Catania, Sicily. Although the camper van
suffered a lack of active support from other drug treatment
agencies and organisations, it slowly was able to establish
contacts with an increasing number of hidden IDUs [38].
Lhomme et al. [21] reported findings of an evaluation of
a NEP in Paris, which introduced mobile vans in its sec-
ond phase. Of those accessing the program, 60% wereHarm Reduction Journal 2007, 4:14 http://www.harmreductionjournal.com/content/4/1/14
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homeless and 46% HIV positive of whom 59% were with-
out medical follow-up.
Complementary or duplication of services?
As evidence for the ability of these two types of NSP out-
lets to reach the hidden, hard-to-rich and high-risk group
of IDUs has accumulated, it would be hoped that they
complement each other and other modes of NSPs. Only
two studies are available that have evaluated both dis-
pensing machines and mobile vans. Agnoletto et al. [24]
studied IDUs who used exchange machines and/or
mobile vans but were not in contact with other health
services in Milan, Italy. The authors concluded that the
need to provide non-judgemental access to counselling
and information justify complementary utilization of
both exchange machines and mobile units as strategies for
harm reduction. This observation is in keeping with the
findings of a Berlin study that found users of vending
machines, low-threshold meeting places and needle-
exchange buses were significantly different in terms of
HIV-rate, history of drug use and contact with counselling
units [28]. Therefore they are different target groups for
HIV-prevention. The most common three recommenda-
tions from IDUs (n = 76) interviewed in Scotland to
improve access and quality of services were (i) outreach
schemes and vending machines (62%), (ii) extending
opening hours (12%) and (iii) more privacy in NEP (9%)
[57]. These findings support the relevance of these two
outlets in the context of other modes of NSP.
The most important advantage of dispensing machines is
their anonymous and off-peak services when other outlets
are closed. The findings of French trials consistently found
that these machines are a useful adjunct to other modes of
NSPs by reaching a different segment of IDUs [39,45]. All
four evaluations [26,32,42,52] and a focus group discus-
sion with IDUs [17] in Australia also supported the com-
plementary role of dispensing machines.
Mobile vans mostly provide a flexible outreach service
and act as a bridge to fixed-site outlets. For example, in
Volgograd (Russian Federation) a fixed-site is augmented
by a bus which serves three networks of drug users who
live far apart in the city that stretches 40 km along the
Volga river [58]. Similarly, Somlai et al. [34] described a
mobile service, Lifepoint, which visits a number of high
traffic areas on a rotating basis. These areas include drug
houses, taverns, parks, and commercial sex areas. The
duration of each visit to each site varies according to drug
house locations, seasonal migrations of clients during
cold weather, and in response to advice from key inform-
ants.
In some countries, amidst strong injecting paraphernalia
law and few or no dispensing machine outlets on the
grounds of importance of health staff contact, the mobile
van can reduce the distance for users to travel to get nee-
dles and syringes. Carrying used syringes for a long peri-
ods in order to exchange presents problems for IDUs in
the presence of police pressure and can dissuade them
from bringing used syringes back [38]. The van reduces
the risk of being caught by a law enforcing agency. Bur-
rows [58] reminds us that forced closure is the most com-
mon reason for NSPs terminating services, and mobile
services are often easier for local residents to cope with
and can prevent or overcome the opposition that is
focused on a fixed-site NSP. On the other hand, some
IDUs in Vancouver mentioned the difficulty in meeting
the mobile van as one of the major challenges [59], an
issue vending machines may address effectively.
Importantly, while dispensing machines ensure great ano-
nymity, they take away the important contact of IDUs
with heath staff. In contrast, mobile vans ensure the con-
tact but reduce anonymity.
Discussion
This review offers evidence to support the notion that dis-
pensing machines and mobile vans can accommodate dif-
ferent patterns of user, diversifying services to meet
various needs. Drug use is not confined to a nine-to-five
schedule. Practitioner-feedback from the only NSP outlet
in Australia that is staffed 24 hours a day and 365 days a
year indicates that close to half of the services are provided
between 6 pm and 6 am [60]. Nevertheless in many parts
of the world, even where NSPs are on a strong platform,
there are few if any access points to sterile injecting equip-
ment during these hours. In such a context, the need for a
24-hour service is gravely felt and syringe dispensing
machines have emerged as a simple and very effective
tool.
It is known that bringing users into contact with people
who can support and promote appropriate behaviour
change is an important aspect of contemporary NSPs [61].
This aspect has been valued so strongly in the NSPs of USA
that it has probably worked against the introduction of
dispensing machines [62]. However, it has also been rec-
ognised that because of the illicit nature of drug use, some
users are reluctant to use services which bring them into
contact with anyone, and even the relatively anonymous
services provided by local pharmacies [63]. For those peo-
ple a non-contact service was needed and dispensing
machines to supply sterile equipment have emerged as an
aid to them.
Syringe dispensing machines are likely to be highly cost
effective, and the main saving is in staff costs. Clearly the
staff costs would be substantial if a 24 hours staffed serv-
ice is provided. Berg [26] found that machines could beHarm Reduction Journal 2007, 4:14 http://www.harmreductionjournal.com/content/4/1/14
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highly self-supporting at lower prices for equipment, and
be highly cost-effective even if the equipment was dis-
pensed free-of-cost. However, this cost saving is based
only on the cost of provision of sterile equipment and
does not take into account the potentially greater health
promotion impact via staff-user contact at staffed NSP
outlets [64]. On the other hand, a mobile van service can
be relatively expensive as, in addition to personnel cost, it
involves the purchase and maintenance of a vehicle and
fuel costs [58].
However, services through mobile vans can be provided at
both locations and times that are compatible with the
IDUs' lives. Mobile vans increase accessibility for clients
who do not have a vehicle or money for transportation,
and/or may be too drug-impaired to drive to the fixed-site.
The importance of having a service close to IDUs was
observed in a study in New York [65]. The authors found
that 81% of IDUs who lived nearby typically used a NEP
compared to 59% of those who lived further away. In
multiple logistic regression analysis, those who lived
nearby remained 3 times more likely (adjusted OR = 2.89;
95% CI 2.06–4.06) to use NEP, and were less likely to
have engaged in receptive syringe sharing at their last
injection (adjusted OR = 0.45, 95% CI 0.24–0.86). There-
fore, locating NSP services in areas convenient to large
numbers of IDUs may be critical for prevention of blood-
borne virus infection. It might not always be possible to
set up fixed-site NSP in all strategically important points
because a range of variables needs to be addressed before
attempting to set-up and then make it responsive to the
need of IDUs. The mobile van can come to aid in resolv-
ing this problem.
Despite having conventional NSPs and pharmacies avail-
able, IDUs might experience several barriers in accessing
sterile equipment. It was found that those who reported
difficulty with accessing sterile needles were 3.5 times
more likely to report needle sharing than were people
without difficulty [66]. Table 2, we developed, describes
some common barriers to NSP access, the majority of
which were reported in a study in Sydney [67]. It also
helps us understand the likely ability of dispensing
machines and mobile vans to improve the accessibility
and acceptability of NSPs to IDUs by addressing several
barriers that IDUs encounter with the conventional NSPs
and pharmacy outlets.
The results of this review do not support one type of NSP
outlet over another, rather they suggest that coexistence of
different modes and tailoring of services offered at differ-
ent venues might be an important consideration. There is
a convincing body of international experience on the
effectiveness of conventional NSPs in providing access to
sterile injecting equipment to IDUs, which in many set-
tings cannot be replaced by other modes [68]. Nor on the
other hand is it feasible to replace the advantages of a
mobile van or dispensing machine by a conventional out-
let. Cox et al. [69] recommends comprehensive NSPs
including pharmacy involvement in distribution, strategi-
cally-placed dispensing machines and mobile exchanges.
Table 2: Standard of good practice of dispensing machine and mobile van to address some common barriers experienced by IDUs in 
accessing sterile injecting equipment from conventional NSPs and pharmacy outlets.
Some common barriers to access Vending Machines' ability to address Mobile Vans' ability to address
Worried about being seen as an IDU Very good Moderate
Do not feel comfortable to visit NSPs Very good Moderate
Worried about being seen by parents/relatives Moderate Moderate
Hours not open when needed Very good Moderate
Pharmacies do not want to sell Very good Very good
Did not like attitudes of pharmacy-staff Very good Very good
Did not know about NSPs Very goodα Very goodα
Too far to travel NSPs or Pharmacies Very goodα Very goodα
Did not like location of NSPs or Pharmacies Very goodα Very good α
Too many police around NSPs Very good Very good
Not easy to travel to NSP and pharmacy Very good α Very good α
NSPs are too busy Very good Very good
NSP too close to a methadone clinic Very good α Very good α
Limited equipment available at once Very goodβ Very good δ
Did not like NSP staff Very good Very good γ
Did not understand the language Very good Moderate
NSPs are male dominated Very good Moderate Ω
α: If strategically important places are covered by dispensing machines and (or) vans; β: If needle-syringes are offered for coin or free of cost; δ: If 
not strict to one-to-one exchange; γ: If peer staff are employed; Ω: It may be very good if services are gender responsive.Harm Reduction Journal 2007, 4:14 http://www.harmreductionjournal.com/content/4/1/14
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This review should be considered in the light of several
limitations. Firstly, only literature published in the Eng-
lish language was reviewed. Subsequent reviews should
consider translating publications in other languages to
capture a greater range of evidence. Secondly, most of the
literature originated from developed countries and may
not be generalizable to the conditions of developing
countries where the vast majority of the world's IDUs now
live. Thirdly, there is a paucity of data even in the grey lit-
erature. In addition, the articles reviewed may be subject
to various biases.
Conclusion
There is persuasive evidence that different venues of NSP
attract different clients. In particular, dispensing machines
and mobile vans are preferred modalities for hidden and
high-risk IDUs. These two modalities can successfully
address concerns about temporal and spatial accessibility
and overall acceptability of NSP. Intrinsic advantages of
each can offset the shortcomings of the other. Despite the
relatively small volume of publications a clear and con-
sistent finding is that these two outlets, if set up properly
in a well chosen location with the local community well
prepared, can generally increase the availability of sterile
injecting equipment at times and places where coverage is
poor. They also may enhance NSP provision through pro-
viding anonymous and confidential access to sterile
injecting equipment for hidden and high-risk groups of
IDUs.
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